Mind Medicine (MindMed) Inc.

NEO: MMED


Canadian symbol: MMED.NE
US symbol: MMEDF

Currency in CAD

Valuation Measures

Market Cap (intraday) 51.28B
Enterprise Value 344.11M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)14.49
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-1.38

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3518.64%
S&P500 52-Week Change 343.61%
52 Week High 35.9900
52 Week Low 30.3950
50-Day Moving Average 33.6794
200-Day Moving Average 33.4401

Share Statistics

Avg Vol (3 month) 31.54M
Avg Vol (10 day) 31.11M
Shares Outstanding 5326.13M
Implied Shares Outstanding 6N/A
Float 286.31M
% Held by Insiders 16.56%
% Held by Institutions 10.57%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-41.54%
Return on Equity (ttm)-75.78%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.89M
Net Income Avi to Common (ttm)-35.34M
Diluted EPS (ttm)-0.1190
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)80.09M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)34.06
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-24.18M
Levered Free Cash Flow (ttm)-11.34M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.




Company News Date
MMED.NE
Mind Medicine (MindMed)
1 month ago
MMED.NE
Mind Medicine (MindMed)
3 months ago
MMED.NE
Mind Medicine (MindMed)
4 months ago
MMED.NE
Mind Medicine (MindMed)
6 months ago
MMED.NE
Mind Medicine (MindMed)
6 months ago
MMED.NE
Mind Medicine (MindMed)
7 months ago
MMED.NE
Mind Medicine (MindMed)
8 months ago
MMED.NE
Mind Medicine (MindMed)
8 months ago
MMED.NE
Mind Medicine (MindMed)
8 months ago
MMED.NE
Mind Medicine (MindMed)
8 months ago
MMED.NE
Mind Medicine (MindMed)
9 months ago
MMED.NE
Mind Medicine (MindMed)
9 months ago
MMED.NE
Mind Medicine (MindMed)
11 months ago
MMED.NE
Mind Medicine (MindMed)
11 months ago
MMED.NE
Mind Medicine (MindMed)
11 months ago
MMED.NE
Mind Medicine (MindMed)
1 year ago
MMED.NE
Mind Medicine (MindMed)
1 year ago
MMED.NE
Mind Medicine (MindMed)
1 year ago
MMED.NE
Mind Medicine (MindMed)
1 year ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
6.56%% of Shares Held by All Insider
0.57%% of Shares Held by Institutions
0.61%% of Float Held by Institutions
9Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Mind Medicine (MindMed) Inc.


Aya Gold & Silver Reports Record Results Including Operating Cash Flow of $3.4 Million in Q4 2020

Record Production and Exploration Activity Forecasted in 2021MONTREAL, March 26, 2021 /CNW Telbec/ - Aya Gold & Silver Inc. (TSX: AYA) ("Aya" or the "Corporation") today reported its financial and operational results for the fourth quarter and year ended December 31, 2020. All amounts are in US dollars unless otherwise stated.Aya Gold... Read More...

WestJet and the Government of British Columbia partner to assist with vaccine clinics in Greater Vancouver

CAMBRIDGE, ON, Feb. 3, 2021 - ATS Automation Tooling Systems Inc. (TSX: ATA) ("ATS") today reported its financial results for the three and nine months ended December 27, 2020.ATS Automation Tooling Systems (CNW Group/ATS Automation Tooling Systems Inc.)Third quarter highlights: Revenues increased 1% year over year to $369.7 million.Earni... Read More...

Planet Water Foundation Brings Life-Changing Access to Clean Drinking Water to Communities Across 5 Countries as Part of World Water Day Activation

"Project 24" week of action sees water filtration systems deployed in Cambodia, India, Mexico, Philippines, and Vietnam PHOENIX, March 22, 2021 -- Planet Water Foundation, a leading non-profit in the fight against water poverty, announces the completion of Project 24, its initiative to make a life-changing impact in communities which lack... Read More...

ADP Canada National Employment Report: Employment in Canada Decreased by 100,800 Jobs in February 2021

TORONTO, March 18, 2021 -- Employment in Canada decreased by 100,800 jobs from January to February according to the February ADP® Canada National Employment Report. Broadly distributed to the public each month, free of charge, the ADP Canada National Employment Report is produced by the ADP Research Institute®. The report, which is derive... Read More...

NexGen Announces Exercise of $22.5 Million Over-Allotment Option in Connection with Recently Completed Bought Deal Financing

Hydro One's focus on customer advocacy, partnerships, and long-term financial stability results in positive performanceTORONTO, Feb. 24, 2021 - Hydro One Limited (Hydro One or the Company) today announced its financial and operating results for the fourth quarter ended December 31, 2020.Hydro One Inc. (CNW Group/Hydro One Limited)Fourth Q... Read More...

Platform Science’s Connected Vehicle Platform for Enterprise Fleets Acclaimed by Frost & Sullivan

Rapidly Growing Cyber Crime Firm Adds Executive Vice President and General CounselWEST PALM BEACH, Fla., Feb. 24, 2021 -- Arete Incident Response, a leading incident response and cyber security provider, today announced the addition of Greg Mazares as Executive Vice President and Mark Cluse as General Counsel. These two executives continu... Read More...

Reimagining SPACE – Engaging the community in the creation of Centennial Place

BEACONSFIELD, QC, Feb. 25, 2021 /CNW Telbec/ - Mayor Georges Bourelle and the members of City Council are pleased to announce an initiative aimed at generating community support for the creation of Centennial Place as part of the Reimagining SPACE revitalization project.City of Beaconsfield LOGO (CNW Group/City of Beaconsfield)In June 201... Read More...

Hydro One Reports Fourth Quarter Earnings

Hydro One's focus on customer advocacy, partnerships, and long-term financial stability results in positive performanceTORONTO, Feb. 24, 2021 - Hydro One Limited (Hydro One or the Company) today announced its financial and operating results for the fourth quarter ended December 31, 2020.Hydro One Inc. (CNW Group/Hydro One Limited)Fourth Q... Read More...

LEAF Mobile’s Subsidiary, East Side Games, Announces Partnership with Kano Applications Inc

VANCOUVER, BC, Feb. 23, 2021 - LEAF Mobile Inc. (TSX: LEAF) ("LEAF" or the "Company") announces its subsidiary company, East Side Games Inc. ("ESG"), has entered into a three game partnership with Kano Applications Inc. ("Kano") for the global release of three mobile games on iOS and Android (the "Partnership").Leaf Mobile logo (CNW Group... Read More...

Engine Media Announces Fully Committed $15 Million in Private Placement; Brings Total Capital Raised to $33 Million

C$ unless otherwise statedTSX/NYSE/PSE: MFC SEHK: 945TORONTO, Feb. 10, 2021 - Manulife's Board of Directors today announced quarterly shareholders' dividends on the following non-cumulative preferred shares of Manulife Financial Corporation, payable on or after March 19, 2021 to shareholders of record at the close of business on February ... Read More...

ATS Reports Third Quarter Fiscal 2021 Results

CAMBRIDGE, ON, Feb. 3, 2021 - ATS Automation Tooling Systems Inc. (TSX: ATA) ("ATS") today reported its financial results for the three and nine months ended December 27, 2020.ATS Automation Tooling Systems (CNW Group/ATS Automation Tooling Systems Inc.)Third quarter highlights: Revenues increased 1% year over year to $369.7 million.Earni... Read More...

MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD

BASEL, Switzerland, Jan. 20, 2021 -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, announced today the start of the first ever clinical trial measuring and evaluating MDMA and LSD used in combination in the human body. The trial will be conducted at the University Hospital Basel Liechti La... Read More...

Ontario Lottery and Gaming Corporation – MidDay lottery winning numbers – January 15, 2021

TORONTO, Jan. 15, 2021 -Friday 15/01/2021PICK-2: 7 8 PICK-3: 7 0 3 PICK-4: 7 2 5 9 ENCORE: 1099158 DAILY KENO1, 3, 7, 12, 17, 21, 22, 26, 27, 31, 34, 39, 43, 50, 52, 55, 59, 60, 63, 68. SOURCE OLG WinnersCisionView original content: http://www.newswire.ca/en/releases/archive/January2021/15/c0117.htmlOriginally published{{monthName}} {{day... Read More...

Qohash Secures $8M in Funding With Cutting-Edge Data Security Solutions Helping Companies Stop Global Increase in Data Breaches

FINANCING TO SUPPORT THE DEVELOPMENT OF MINDMED'S DIGITAL MEDICINE DIVISION AND PSYCHEDELIC INSPIRED MEDICINES AND EXPERIENTIAL THERAPIESNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Jan. 4, 2021 -- Mind Medicine (MindMed) Inc. (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ) ("MindMed" or... Read More...

MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience

Psychedelic Pharmaceutical Scientist and Clinical Pharmacologist Robert Barrow Appointed as Chief Development OfficerNEW YORK, Jan. 14, 2021 -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company today announced the addition of Robert Barrow, an accomplished pharmaceutical executive, as Chief Dev... Read More...

MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers

MindMed to Commence Groundbreaking LSD Microdosing Study Evaluating Benefits on Neuroplasticity, Sleep, Cognitive Enhancement Variables and Immune System Response on the Human Body NEW YORK, Jan. 12, 2021 -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company today announced an innovative randomi... Read More...

Innovative Tennant Decorative Stone Slurry™ System by Tennant Coatings Elevates Epoxy Flooring with Groundbreaking Functional Benefits and New Luxury Look

CHICAGO, Jan. 11, 2021 -- Tennant Coatings, Inc., industry-leading manufacturer of commercial, institutional and industrial coating systems for concrete floors has launched the innovative new Tennant Decorative Stone SlurryTM System. This epoxy flooring advancement features a unique luxury aesthetic with stunning color saturation and stri... Read More...

MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand

Bolsters Cash on Hand to CAD $183.0m (USD $144.4m)NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Jan. 7, 2021 -- Mind Medicine (MindMed) Inc. (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ) ("MindMed") is pleased to announce that it has closed its previously announced bought deal short for... Read More...

Four Top Psychedelic Stock Picks for 2021

The Top Companies Addressing Mental Health CrisisATLANTA, Jan. 04, 2021 -- 2020 was a banner year for investors in psychedelic companies as investors in Mind Medicine (MindMed) Inc. (OTCQB: MMEDF), 20/20 Global, Inc. (OTC: TWGL), Compass Pathways (NASDAQ: CMPS), and Numinus Wellness Inc. (OTC: LKYSF) saw their money triple and even quadru... Read More...

MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy

Provides Clinical Development Update on 18-MCBased on positive pre-IND meeting with U.S. Food and Drug Administration (FDA), MindMed is now prepared to open an Investigational New Drug (IND) in August 2021 with a Phase 2b clinical trial for LSD assisted therapy in anxietyMindMed continues dose escalation of 18-MC in Phase I SAD/MAD; Meeti... Read More...

BakeMark Expands Sup-R-Shop™ Digital Platform

LOS ANGELES, Dec. 1, 2020 -- BakeMark announces the expansion of the best digital online ordering solution to the bakery community, Sup-R-Shop™. Online ordering, as an option, has been available to BakeMark customers since 2008."At BakeMark, we've always been focused on helping our customers succeed. We deliver unmatched service through o... Read More...

Statement from Huawei Canada

OTTAWA, ON, Nov. 19, 2020 - Antimicrobial resistance is a growing public health threat in Canada and worldwide. This is a global issue which requires global consideration and innovation.World Antimicrobial Awareness Week, from November 18-24, provides us with an opportunity to learn about the important actions we can take to maintain the ... Read More...

MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines

NEW YORK, Nov. 24, 2020 -- MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company, is establishing a digital medicine division known as Albert. Albert is in the process of assembling and recruiting a leading team of technologists, therapists, and clinical drug development experts to help the company r... Read More...

Statement from the Chief Public Health Officer of Canada – World Antimicrobial Awareness Week 2020

OTTAWA, ON, Nov. 19, 2020 - Antimicrobial resistance is a growing public health threat in Canada and worldwide. This is a global issue which requires global consideration and innovation.World Antimicrobial Awareness Week, from November 18-24, provides us with an opportunity to learn about the important actions we can take to maintain the ... Read More...

MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

Project Lucy Submits Pre-IND Briefing Package to the FDA; Agrees Q1 Interim Analysis of Swiss Phase 2a Trial of LSD Assisted Therapy for Anxiety DisordersNEW YORK and BASEL, Switzerland, Nov. 16, 2020 -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, has received a positive response on its ... Read More...

MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD

Data to Support MindMed's Project Lucy in Preparing Phase 2b Trial for Anxiety DisordersNEW YORK, Nov. 2, 2020 -- MindMed (NEO: MMED, OTCQB: MMEDF), the leading psychedelic medicine biotech company in partnership with University Hospital Basel's Liechti Lab announces the completion and publication of a Phase 1 study on the acute dose depe... Read More...

MindMed Closes Upsized Financing of CAD $28.75m With Strong Institutional Demand for Psychedelic Medicines

Post-Financing Cash Reserves of CAD $50.1m (USD $37.8m) to Enable Continued Advancement of Diverse and Growing Clinical Trial Pipeline of PsychedelicsNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Oct. 30, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED, OTCQB: MMEDF) ("MindMed" o... Read More...

MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

MindMed To Provide Funding for Psychedelic Medicine Research Training Program at NYU Langone Health and NYU Grossman School of Medicine NEW YORK, Oct. 5, 2020 -- MindMed (NEO: MMED) (OTCQB: MMEDF), the leading psychedelic medicine biotech company, on the heels of filing a NASDAQ uplisting application, today announced a funding commitment ... Read More...

MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor

NEW YORK, Sept. 21, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED)(OTCQB: MMEDF)(DE: MMQ), the leading drug development company for psychedelic inspired medicines, is evaluating an expanded United States investor base through an up-listing on the NASDAQ Capital Market ("NASDAQ").Mindmed logo (PRNewsfoto/Mind Medicine, Inc. (Mindmed))As ... Read More...

Mainstream Renewable Power Closes Second Phase of c.US$1.8 billion Wind and Solar Financing Deal in Chile

MindMed is funding a Phase 1 Clinical Trial at University Hospital Basel Liechti LabNEW YORK, Aug. 25, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines and the University Hospital Basel's Liechti Lab are now combining MDMA and LSD in a groundbreaking... Read More...

MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

Applauds Health Canada's Approval Of Psilocybin Compassionate Access For PatientsNEW YORK, Aug. 6, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has engaged renowned psychedelic assisted therapy expert Dr. Peter Gasser as an advisor to its LSD experiential therapy program Pr... Read More...

MindMed Completes Dosing 18-MC Phase 1 Study

Company, seeing early success, will advance preparations for Phase 2a clinical trial in opioid addictionNEW YORK, July 28, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has concluded dosing in a Phase 1 Single Ascending Dose (SAD) study of 18-MC. The dosing of 18-MC was well... Read More...
Coming Soon.

Delayed data (1h)


Share this page